The in vitro activities of new P-lactam antibiotics was studied and compared Several ,-lactam antibiotics, mostly semisynthetic in nature, have been developed in the last few years. These antibiotics have multiple advantages that include good distribution, minimal toxicity, broad spectra of activity, high achievable serum concentrations, resistance to degradation by ,B-lactamases, and prolonged half-lives (1-5, 8). Because of these properties, the majority of these antimicrobial agents can be evaluated in immunocompromised patients. Acinetobacter calcoaceticus has assumed significance in treating clinical infections and was isolated at our institution from the blood of 132 patients on 157 occasions over a period of 6 years. Of the 157 positive blood cultures, 107 (68%) were
Several ,-lactam antibiotics, mostly semisynthetic in nature, have been developed in the last few years. These antibiotics have multiple advantages that include good distribution, minimal toxicity, broad spectra of activity, high achievable serum concentrations, resistance to degradation by ,B-lactamases, and prolonged half-lives (1) (2) (3) (4) (5) 8) . Because of these properties, the majority of these antimicrobial agents can be evaluated in immunocompromised patients. Acinetobacter calcoaceticus has assumed significance in treating clinical infections and was isolated at our institution from the blood of 132 patients on 157 occasions over a period of 6 years. Of the 157 positive blood cultures, 107 (68%) were obtained from January 1981 through October 1982. These organisms have been shown to be resistant to a considerable number of antimicrobial agents (1) (2) (3) (4) (5) (6) (7) (8) was determined br subculturing 0.01 ml of medium containing 10 organisms and defined as the lowest concentration of drug that resulted in -99.9% killing of the organism in the original inoculum after 18 h of incubation at 37°C.
The 25 antibiotics used were obtained from different pharmaceutical companies. Imipemide (N-formimidoyl thienamycin) was the most active drug of the new 3-lactam antibiotics, inhibiting 50% of both subspecies tested at a concentration of 0.20 ,ug/ml (Tables 1 and 2 .56->100 6.25->100 3.12->100 3.12->100 1.56-100 0.39-25 0.39->100 6.25->100 1.56-25 3.12-100 6.25->100 12.5->100 3.12->100 3.12->100 3.12->100 1.56->100 0.05-12.5 0.78->100 12.5->100 0.78->100 
